EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Limited Efficacy of Autologous Mesenchymal Stromal Cell Injections in Immunomodulatory‐Dependent Dogs With Aqueous Deficient Dry Eye Disease

Brian C Leonard iD, Shin Ae Park iD, Sun Young Kim iD, Kei Hayashi, Sara M Thomasy iD, Vanessa Rozo, Monica J Motta, Dori L Borjesson, Christopher J Murphy iD, Kathryn L Good iD

Veterinary Ophthalmology · 2026

DOI: 10.1111/vop.70233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Ophthalmology, 2026. Verfasst von Brian C Leonard und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, USA. Hauptthemen laut MEDLINE: Dog Diseases, Mesenchymal Stem Cell Transplantation, Dry Eye Syndromes. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS, UC Davis Center for Equine Health, Gift from Mr. Dick and Carolyn Randall.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Aqueous deficient dry eye disease (ADDE) results from a quantitative reduction in aqueous tears. We sought to determine the clinical effect of autologous mesenchymal stromal cell (MSC) injections into the region of the lacrimal gland and the gland of the third eyelid in immunomodulatory‐dependent ADDE‐affected dogs.

Methods

Dogs ( n = 4) were enrolled that met the inclusion criteria for ADDE (consistent clinical signs combined with Schirmer tear test I [STT‐I] value < 15 mm/min, responsive to topical immunomodulatory therapy, and documented drop in STT‐I after cessation of therapy). By applying these stringent criteria, there was a high failure rate for inclusion. Autologous MSCs were harvested, expanded, and unilaterally injected after cessation of immunomodulatory therapy. Examinations, ophthalmic diagnostics, clinical scoring, and owner surveys were performed at regular intervals post‐injection.

Results

No adverse ocular events were associated with the MSC injections. There were variable responses between dogs, with one dog exhibiting an immediate increase in STT‐I that remained elevated (5.5‐fold increase); two dogs had a smaller and temporary increase in STT‐I over baseline (0.6–0.7‐fold increases), and one dog had no increases detected over the initial 6 months. Repeated injections did not improve clinical or diagnostic values.

Conclusions

Autologous MSC injections were well‐tolerated in dogs with ADDE. Results were variable in this small sample size. Despite initial improvement in 3 of 4 dogs, the positive response was variable in magnitude of response and duration of effect. Repeated injections did not sustain this response. Future studies using conditioned MSCs and/or exosomal therapy are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesMesenchymal Stem Cell TransplantationDry Eye SyndromesAnimalsDogsFemaleMaleTransplantation, AutologousTearsTreatment OutcomeLacrimal Apparatus

Stichwörter der Autor:innen

Keratoconjunctivitis Siccaaqueous deficient dry eyecaninemesenchymal stromal cellstear film

Autor:innen und Institutionen

  • Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, USA.
  • Department of Ophthalmology & Vision Science, School of Medicine, University of California, Davis, Davis, CA, USA.
  • Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN, USA.
  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
  • Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, CA, USA.
  • Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA, USA.

ORCID-Profile: Brian C Leonard, Shin Ae Park, Sun Young Kim, Sara M Thomasy, Christopher J Murphy, Kathryn L Good

Förderung

  • NEI NIH HHS
  • UC Davis Center for Equine Health
  • Gift from Mr. Dick and Carolyn Randall
  • National Eye Institute

Zitieren

APA

Leonard, B. C., Park, S. A., Kim, S. Y., Hayashi, K., Thomasy, S. M., Rozo, V., Motta, M. J., Borjesson, D. L., Murphy, C. J., & Good, K. L. (2026). Limited Efficacy of Autologous Mesenchymal Stromal Cell Injections in Immunomodulatory‐Dependent Dogs With Aqueous Deficient Dry Eye Disease. Veterinary Ophthalmology. https://doi.org/10.1111/vop.70233

Vancouver

Leonard BC, Park SA, Kim SY, Hayashi K, Thomasy SM, Rozo V, et al. Limited Efficacy of Autologous Mesenchymal Stromal Cell Injections in Immunomodulatory‐Dependent Dogs With Aqueous Deficient Dry Eye Disease. Veterinary Ophthalmology. 2026. doi:10.1111/vop.70233

BibTeX
@article{Leonard2026,
  author = {Leonard, Brian C and Park, Shin Ae and Kim, Sun Young and Hayashi, Kei and Thomasy, Sara M and Rozo, Vanessa and Motta, Monica J and Borjesson, Dori L and Murphy, Christopher J and Good, Kathryn L},
  title = {Limited Efficacy of Autologous Mesenchymal Stromal Cell Injections in Immunomodulatory‐Dependent Dogs With Aqueous Deficient Dry Eye Disease},
  journal = {Veterinary Ophthalmology},
  year = {2026},
  doi = {10.1111/vop.70233}
}
Kostenlos starten →